7771 - 7780 of 9145 Results
Title
Year
- The Linked Clinical Trials initiative (LCT) for Parkinson's disease2018RESTRICTEDTitle: The Linked Clinical Trials initiative (LCT) for Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 307End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14175Citation Count: 20
-
OPENTitle: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 3Start Page: 503End Page: 517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2955774Citation Count: 279
- Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains2025OPENTitle: Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brainsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 1Start Page: eadn1927End Page: eadn1927Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adn1927Best OA location URL: https://doi.org/10.1126/sciadv.adn1927Citation Count: 6
-
OPENTitle: Sustained attention training reduces spatial bias in Parkinson’s disease: a pilot case seriesJournal Name: NeurocasePublisher: Informa UK LimitedVol: 22Issue #: 2Start Page: 179End Page: 186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13554794.2015.1088035Best OA location URL: http://doi.org/10.1080/13554794.2015.1088035Citation Count: 15
-
OPENTitle: Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population‐based elderly cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 12Issue #: 12Start Page: 1226End Page: 1234Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2016.06.001Best OA location URL: http://doi.org/10.1016/j.jalz.2016.06.001Citation Count: 154
-
RESTRICTEDTitle: Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson DiseaseJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 97Issue #: 5Start Page: 23End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2015.12.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4844795Citation Count: 0
-
OPENTitle: A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatisJournal Name: Antimicrobial Agents and ChemotherapyPublisher: American Society for MicrobiologyVol: 65Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/aac.01826-20Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8092867Citation Count: 7
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9990146Citation Count: 63
-
OPENTitle: Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brainJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 46Issue #:Start Page: 128164End Page: 128164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2021.128164Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8379902Citation Count: 15
-
OPENTitle: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 4Start Page: 596End Page: 602Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9350900Citation Count: 52